Nordisk
- Top Stories
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Novo Nordisk is taking legal action against online telehealth provider Hims & Hers for marketing cheaper, unapproved versions of the…
Read More » - Finance
Novo Nordisk A/S (NVO) Eyes Solidifying Its Market Position with Increased Advertising Spending
Novo Nordisk A/S (NYSE:NVO) has recently been highlighted as one of the 13 Best Extremely Profitable Stocks to Invest in…
Read More » - Money
Novo Nordisk debuts Wegovy weight-loss pill in the U.S.
Novo Nordisk, a Danish drugmaker, has introduced an oral pill form of their weight-loss drug Wegovy in the U.S. This…
Read More » - Top Stories
Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Novo Nordisk’s stock saw a significant increase of 6.9% on Tuesday following the approval of its groundbreaking GLP-1 pill by…
Read More » - Money
Novo Nordisk says it’s cutting 9,000 workers amid increased competition for its obesity drug Wegovy
Novo Nordisk, a Danish pharmaceutical company known for its weight-loss drug Wegovy, announced on Wednesday that it will be cutting…
Read More » - Business
Wegovy-maker Novo Nordisk cutting 9000 jobs in restructuring
Novo Nordisk, the maker of Wegovy, announced a significant restructuring plan that will result in 9,000 job cuts, representing about…
Read More » - Health
Novo Nordisk, Regeneron, CDC shooting
The Centers for Disease Control and Prevention (CDC) in Atlanta recently faced a terrifying incident when a shooter attempted to…
Read More » - Money
Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook
Novo Nordisk, a Danish pharmaceutical company, faced a significant setback on Tuesday as its shares plummeted by over 20%. The…
Read More » - Money
Novo Nordisk halts Wegovy sales on Hims & Hers, claiming “deceptive marketing” practices
Novo Nordisk Ends Partnership with Hims & Hers Health Over Fake Weight-Loss Drug Claims Novo Nordisk recently made the decision…
Read More » - Money
Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
Novo Nordisk, the pharmaceutical company behind the popular weight loss drug Wegovy, announced on Friday that its CEO, Lars Fruergaard…
Read More »